Every open market buy and sale of Travere Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $110M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when TVTX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an TVTX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every TVTX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Eric M DubeCEO | Sale plan | 243,735 | $53.82 | $13.1M | 432,886 | Oct 19Form 4 |
| Sep 17, 2026 | Eric M DubeCEO | Sale plan | 400,000 | $63.48 | $25.4M | 432,886 | Sep 17Form 4 |
| Sep 17, 2026 | Peter HeermaEvp, Chief Commercial Officer | Sale plan | 283,189 | $63.06 | $17.9M | 117,066 | Sep 17Form 4 |
| Sep 16, 2026 | William E. RoteChief Research Officer | Sale plan | 209,048 | $62.83 | $13.1M | 98,197 | Sep 17Form 4 |
| Sep 15, 2026 | Elizabeth E ReedChief Legal Officer and GC | Sale plan | 37,500 | $62.34 | $2.3M | 105,389 | Sep 17Form 4 |
| Sep 15, 2026 | Sandra CalvinSvp, Chief Accounting Officer | Sale plan | 5,375 | $62.33 | $335K | 42,353 | Sep 17Form 4 |
| Sep 15, 2026 | Jula InrigEVP, Head of R&D & CMO | Sale plan | 44,674 | $62.34 | $2.8M | 100,491 | Sep 17Form 4 |
| Sep 15, 2026 | Christopher R. ClineCFO | Sale plan | 50,508 | $62.34 | $3.1M | 87,508 | Sep 17Form 4 |
| Sep 10, 2026 | Jeffrey A MecklerDirector | Sale plan | 20,000 | $67.31 | $1.3M | 91,500 | Sep 11Form 4 |
| Sep 2, 2026 | Christopher R. ClineCFO | Sale | 642 | $66.37 | $43K | 118,016 | Sep 3Form 4 |
| Aug 18, 2026 | Gary A LyonsDirector | Sale plan | 10,000 | $63.28 | $633K | 61,500 | Aug 19Form 4 |
| Jun 12, 2026 | Timothy CoughlinDirector | Sale plan | 10,000 | $50.07 | $501K | 56,250 | Jun 16Form 4 |
| Jun 12, 2026 | Roy D. BaynesDirector | Sale plan | 4,500 | $50.00 | $225K | 41,500 | Jun 16Form 4 |
| May 15, 2026 | Timothy CoughlinDirector | Sale plan | 3,250 | $43.49 | $141K | 52,250 | May 19Form 4 |
| May 6, 2026 | Elizabeth E ReedChief Legal Officer and GC | Sale plan | 24,250 | $45.06 | $1.1M | 105,211 | May 6Form 4 |
TVTX insider trading FAQ
Are TVTX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of TVTX on the open market in 0 trades, and 11 sold $110M in 57 trades, 99% of that under pre-arranged trading plans.
When did an TVTX insider last buy shares?
There has been no open market insider purchase of TVTX in the last two years.
When did an TVTX insider last sell shares?
Eric M Dube (CEO) sold 243,735 shares for $13.1M on Oct 15, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
